{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:03:06Z","timestamp":1791946986973,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12325-025-03120-y","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:44:30Z","timestamp":1739958270000},"page":"1783-1799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps"],"prefix":"10.1007","volume":"42","author":[{"given":"Anju","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Near","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Spahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-jung S.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tham T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Tuly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-7336","authenticated-orcid":false,"given":"Christopher S.","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"11","key":"3120_CR1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1080\/03007995.2020.1815682","volume":"36","author":"S Chen","year":"2020","unstructured":"Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. 2020;36(11):1897\u2013911.","journal-title":"Curr Med Res Opin"},{"key":"3120_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JAA.S321017","volume":"15","author":"M Al-Ahmad","year":"2022","unstructured":"Al-Ahmad M, Alsaleh S, Al-Reefy H, Al Abduwani J, Nasr I, Al Abri R, et al. Expert opinion on biological treatment of chronic rhinosinusitis with Nasal Polyps in the Gulf Region. J Asthma Allergy. 2022;15:1\u201312.","journal-title":"J Asthma Allergy"},{"issue":"6","key":"3120_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","volume":"10","author":"J Mullol","year":"2022","unstructured":"Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA. Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Allergy Clin Immunol Pract. 2022;10(6):1434\u201353.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"3120_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/alr.21172","volume":"3","author":"WW Thomas 3rd","year":"2013","unstructured":"Thomas WW 3rd, Harvey RJ, Rudmik L, Hwang PH, Schlosser RJ. Distribution of topical agents to the paranasal sinuses: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013;3(9):691\u2013703.","journal-title":"Int Forum Allergy Rhinol"},{"key":"3120_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","volume":"10","author":"V Hox","year":"2020","unstructured":"Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10:1.","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"3120_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.otc.2010.04.003","volume":"43","author":"DM Poetker","year":"2010","unstructured":"Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010;43(4):753\u201368.","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"3120_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","volume":"125","author":"T Van Zele","year":"2010","unstructured":"Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069\u201376.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3120_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/lary.26391","volume":"127","author":"AS DeConde","year":"2017","unstructured":"DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127(3):550\u20135.","journal-title":"Laryngoscope"},{"issue":"5","key":"3120_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00005537-200405000-00004","volume":"114","author":"R Wynn","year":"2004","unstructured":"Wynn R, Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngoscope. 2004;114(5):811\u20133.","journal-title":"Laryngoscope"},{"issue":"3","key":"3120_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","volume":"11","author":"RR Orlandi","year":"2021","unstructured":"Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213\u2013739.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"3120_CR11","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jaip.2022.02.034","volume":"10","author":"S Cai","year":"2022","unstructured":"Cai S, Xu S, Lou H, Zhang L. Comparison of different biologics for treating chronic rhinosinusitis with nasal polyps: a network analysis. J Allergy Clin Immunol Pract. 2022;10(7):1876\u201386.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"3120_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","volume":"147","author":"C Bachert","year":"2021","unstructured":"Bachert C, Han JK, Wagenmann M, Hosemann W, Lee SE, Backer V, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29\u201336.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"3120_CR13","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","volume":"7","author":"WW Stevens","year":"2019","unstructured":"Stevens WW, Peters AT, Tan BK, Klingler AI, Poposki JA, Hulse KE, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7(8):2812-20.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"3120_CR14","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","volume":"137","author":"P Tomassen","year":"2016","unstructured":"Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. Je4 Allergy Clin Immunol. 2016;137(5):1449\u201356.","journal-title":"Je4 Allergy Clin Immunol."},{"issue":"3","key":"3120_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000519228","volume":"183","author":"Q Wu","year":"2022","unstructured":"Wu Q, Zhang Y, Kong W, Wang X, Yuan L, Zheng R, et al. Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis. Int Arch Allergy Immunol. 2022;183(3):279\u201388.","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"3120_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2023.104106","volume":"45","author":"C Galletti","year":"2024","unstructured":"Galletti C, Ragusa M, Sireci F, Ciodaro F, Barbieri MA, Giunta G, et al. Dupilumab in chronic rhinosinusitis with nasal polyps: real life data in a multicentric Sicilian experience. Am J Otolaryngol. 2024;45(1): 104106.","journal-title":"Am J Otolaryngol"},{"key":"3120_CR17","unstructured":"IQVIA. Longitudinal access and adjudication data (LAAD) 2023 [updated September 14, 2023. https:\/\/www.iqvia.com\/locations\/united-states\/library\/fact-sheets\/longitudinal-access-and-adjudication-data."},{"key":"3120_CR18","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2023."},{"issue":"6","key":"3120_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3120_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13223-023-00855-7","volume":"19","author":"J Silver","year":"2023","unstructured":"Silver J, Packnett E, Park J, Deb A. Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study. Allergy Asthma Clin Immunol. 2023;19(1):104.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"3120_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2500\/ar.2015.6.0120","volume":"6","author":"EH Ference","year":"2015","unstructured":"Ference EH, Tan BK, Hulse KE, Chandra RK, Smith SB, Kern RC, et al. Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis. Allergy Rhinol (Providence). 2015;6(2):82\u20138.","journal-title":"Allergy Rhinol (Providence)"},{"issue":"12","key":"3120_CR22","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1016\/j.jaip.2022.08.021","volume":"10","author":"AU Luong","year":"2022","unstructured":"Luong AU, Chua A, Alim BM, Olsson P, Javer A. Allergic fungal rhinosinusitis: the role and expectations of biologics. J Allergy Clin Immunol Pract. 2022;10(12):3156\u201362.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"3120_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.wjorl.2018.08.003","volume":"4","author":"MA Tyler","year":"2018","unstructured":"Tyler MA, Luong AU. Current understanding of allergic fungal rhinosinusitis. World J Otorhinolaryngol Head Neck Surg. 2018;4(3):179\u201385.","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"issue":"12","key":"3120_CR24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.15537\/smj.2023.44.12.20230396","volume":"44","author":"YA Fageeh","year":"2023","unstructured":"Fageeh YA, Basurrah MA, Hakami KT, Almalki ZA, Alnemari FS, Altalhi WA. Risk factors for recurrence of chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery: a retrospective study. Saudi Med J. 2023;44(12):1254\u20139.","journal-title":"Saudi Med J"},{"issue":"5","key":"3120_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jaci.2013.07.009","volume":"132","author":"SS Smith","year":"2013","unstructured":"Smith SS, Evans CT, Tan BK, Chandra RK, Smith SB, Kern RC. National burden of antibiotic use for adult rhinosinusitis. J Allergy Clin Immunol. 2013;132(5):1230\u20132.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3120_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/coa.12787","volume":"42","author":"A Lasso","year":"2017","unstructured":"Lasso A, Masoudian P, Quinn JG, Cowan J, Labajian V, Bonaparte JP, et al. Long-term low-dose macrolides for chronic rhinosinusitis in adults\u2014a systematic review of the literature. Clin Otolaryngol. 2017;42(3):637\u201350.","journal-title":"Clin Otolaryngol"},{"issue":"1","key":"3120_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mayocp.2014.09.006","volume":"90","author":"SP Sadarangani","year":"2015","unstructured":"Sadarangani SP, Estes LL, Steckelberg JM. Non-anti-infective effects of antimicrobials and their clinical applications: a review. Mayo Clin Proc. 2015;90(1):109\u201327.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"3120_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jaci.2022.02.004","volume":"149","author":"SS Smith","year":"2022","unstructured":"Smith SS, Kim R, Douglas R. Is there a role for antibiotics in the treatment of chronic rhinosinusitis? J Allergy Clin Immunol. 2022;149(5):1504\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3120_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/pds.1547","volume":"17","author":"SB Meropol","year":"2008","unstructured":"Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf. 2008;17(5):523\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"26","key":"3120_CR30","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"issue":"4","key":"3120_CR31","doi-asserted-by":"publisher","first-page":"2000151","DOI":"10.1183\/13993003.00151-2020","volume":"56","author":"T Harrison","year":"2020","unstructured":"Harrison T, Canonica GW, Chupp G, Lee J, Schleich F, Welte T, et al. Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis. Eur Respir J. 2020;56(4):2000151.","journal-title":"Eur Respir J"},{"issue":"5","key":"3120_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.anai.2021.01.012","volume":"126","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, Bachert C, Amin N, Desrosiers M, Hellings PW, Mullol J, et al. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol. 2021;126(5):584-92.e1.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"3120_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jaip.2019.07.011","volume":"8","author":"P Li","year":"2020","unstructured":"Li P, Kavati A, Puckett JT, Jahnke J, Busse P, Hanania NA, et al. Omalizumab treatment patterns among patients with asthma in the US Medicare population. J Allergy Clin Immunol Pract. 2020;8(2):507-15.e10.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03120-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:37:22Z","timestamp":1744130242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03120-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03120-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anju T. Peters has received fees for sponsored research from AstraZeneca, Merck and Sanofi, and consultancy fees from AstraZeneca, Chiesi, GSK, Merck, Eli Lilly, and Sanofi. Joseph K. Han has received consultancy fees from AstraZeneca, Genentech, Gossamer Bio, GSK, Novartis, Regeneron Pharmaceuticals and Sanofi. Joseph D. Spahn, Sze-jung S. Wu, Tham T Le, and Christopher S. Ambrose are employees of AstraZeneca and may own stock or stock options in AstraZeneca. Andrew W. Lindsley is an employee of Amgen and owns stock in Amgen. Rifat Tuly, Elizabeth J.\u00a0Wang, Xiaohui Zhao and Aimee M. Near are employees of IQVIA, which received funding from AstraZeneca to conduct the research study. Inyoung Lee was an employee of IQVIA during the study conduct and is currently employed by AbbVie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"As a retrospective study using secondary data, no interventions were made to patients during this study. In compliance with the Health Insurance Portability and Accountability Act (HIPAA), patient data included in the analyses were de-identified; therefore, this study was exempt from Institutional Review Board (IRB) review. Permission was obtained to access and use the data from the IQVIA longitudinal prescription (LRx) and medical claims (Dx) databases, which are owned by IQVIA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}